Skip to main content
. 2021 Apr 10;2021:6695663. doi: 10.1155/2021/6695663

Figure 7.

Figure 7

Expression of lymphocyte marker CD3 and angiogenesis marker CD31 at the defect site. (a) Immunofluorescence microscopy showing endothelial cell immunostaining for CD31 (red) and measurement and analysis of CD31-positive cells. (b) Immunofluorescence microscopy showing endothelial cell immunostaining for CD3 (red) and measurement and analysis of CD3-positive cells.